THURSDAY, Oct. 28, 2021 (HealthDay News) — A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients’ risk of serious illness requiring hospitalization, according to a new study. The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2Continue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — A deal for Merck’s COVID-19 pill to be made and sold cheaply in poor nations has been reached with Medicines Patent Pool, a United Nations-backed nonprofit organization. The royalty-free license means that companies in 105 countries, mostly in Africa and Asia, can sublicenseContinue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 complications in mid-October despite being fully vaccinated. But Powell, 84, was being treated for blood cancer at the time of his death, and a new study reportsContinue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — After prostate cancer surgery, men can safely undergo fewer radiation treatments at higher doses, a new clinical trial shows. Researchers found that the shorter regimen — given over five weeks, instead of seven — did not raise patients’ odds of lasting side effects.Continue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Demand for liver transplants among heavy drinking Americans surged during the COVID-19 pandemic, a new study shows. It found that the number of people with alcoholic hepatitis who received a new liver (32,320) or were put on a liver transplant waiting list (51,488)Continue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Severely immunocompromised people may require a fourth mRNA coronavirus shot, the U.S. Centers for Disease Control and Prevention says. The agency didn’t provide an official recommendation about a fourth shot in its updated guidelines, but did say that people should talk to theirContinue Reading
WEDNESDAY, Oct. 27, 2021 (HealthDay News) — People who’ve lost their ability to smell and taste due to COVID-19 have significant struggles, but they can find ways to cope with their situation, a new study shows. One of the most common side effects of COVID-19 is the loss of theContinue Reading
TUESDAY, Oct. 26, 2021 (HealthDay News) — A U.S. Food and Drug Administration advisory panel voted Tuesday to recommend emergency use of a smaller dose of Pfizer’s coronavirus vaccine for children aged 5 to 11, advancing plans to offer the shots to 28 million young kids across the United States.Continue Reading
TUESDAY, Oct. 26, 2021 (HealthDay News) — Can offering small cash cards, say for $25, be the difference between someone choosing to get their COVID-19 vaccine or waiting? Yes, according to a study in North Carolina that offered $25 cash cards to people who got vaccines last spring at sitesContinue Reading
TUESDAY, Oct. 26, 2021 (HealthDayNews) — If you suffer from severe allergies and worry about the side effects of COVID-19 vaccines, you can relax: A new study shows that even when people report a history of severe allergic reactions to medications, vaccines or allergens, nearly all of them can beContinue Reading